Randomized Study of Pre-Prostatectomy Celecoxib or Placebo

Trial Profile

Randomized Study of Pre-Prostatectomy Celecoxib or Placebo

Phase of Trial: Phase II

Latest Information Update: 03 May 2017

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Aug 2016 Primary endpoint (Apoptosis Index, defined as the percent positive staining cells) has not been met, according to the results published in the BJU International.
    • 01 Aug 2016 Results published in the BJU International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top